newsIGV-001 demonstrates success against glioblastoma in Phase Ib trial27 January 2021 | By Victoria Rees (European Pharmaceutical Review)Imvax's Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma has shown positive results.